Statin use not associated with improved outcomes in patients treated with brachytherapy for prostate cancer

Brachytherapy

Volumn 14, Issue 2, 2015, Pages 179-184

  Cuaron, John ^a   Pei, Xin ^a   Cohen, Gil'ad N ^a   Cox, Brett W ^a   Yamada, Yoshiya ^a   Zelefsky, Michael J ^a   Kollmeier, Marisa A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Brachytherapy; Prostate cancer; Statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROSTATE SPECIFIC ANTIGEN;

ADULT; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BRACHYTHERAPY; CANCER SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; GLEASON SCORE; HOSPITALIZATION; HUMAN; INTERMEDIATE RISK PATIENT; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSTATE CANCER; RETROSPECTIVE STUDY; AGED; BLOOD; FOLLOW UP; PROCEDURES; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

AGED; BRACHYTHERAPY; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84924076707     PISSN: 15384721     EISSN: 18731449     Source Type: Journal    
DOI: 10.1016/j.brachy.2014.05.019     Document Type: Article

References (21)

1. LaRosa J.C., He J., Vupputuri S. Effect of statins on risk of coronary disease: A meta-analysis of randomized controlled trials. JAMA 1999, 282:2340-2346.
2. Yokomizo A., Shiota M., Kashiwagi E., et al. Statins reduce the androgen sensitivity and cell proliferation by decreasing the androgen receptor protein in prostate cancer cells. Prostate 2011, 71:298-304.
3. Platz E.A., Leitzmann M.F., Visvanathan K., et al. Statin drugs and risk of advanced prostate cancer. J Natl Cancer Inst 2006, 98:1819-1825.
4. Hamilton R.J., Banez L.L., Aronson W.J., et al. Statin medication use and the risk of biochemical recurrence after radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database. Cancer 2010, 116:3389-3398.
5. Gutt R., Tonlaar N., Kunnavakkam R., et al. Statin use and risk of prostate cancer recurrence in men treated with radiation therapy. J Clin Oncol 2010, 28:2653-2659.
6. Kollmeier M.A., Katz M.S., Mak K., et al. Improved biochemical outcomes with statin use in patients with high-risk localized prostate cancer treated with radiotherapy. Int J Radiat Oncol Biol Phys 2011, 79:713-718.
7. Zaorsky N.G., Buyyounouski M.K., Li T., et al. Aspirin and statin nonuse associated with early biochemical failure after prostate radiation therapy. Int J Radiat Oncol Biol Phys 2012, 84:e13-e17.
8. Soto D.E., Daignault S., Sandler H.M., et al. No effect of statins on biochemical outcomes after radiotherapy for localized prostate cancer. Urology 2009, 73:158-162.
9. Moyad M.A., Merrick G.S., Butler W.M., et al. Statins, especially atorvastatin, may favorably influence clinical presentation and biochemical progression-free survival after brachytherapy for clinically localized prostate cancer. Urology 2005, 66:1150-1154.
10. Zelefsky M.J., Yamada Y., Cohen G., et al. Postimplantation dosimetric analysis of permanent transperineal prostate implantation: Improved dose distributions with an intraoperative computer-optimized conformal planning technique. Int J Radiat Oncol Biol Phys 2000, 48:601-608.
11. Yamada Y., Bhatia S., Zaider M., et al. Favorable clinical outcomes of three-dimensional computer-optimized high-dose-rate prostate brachytherapy in the management of localized prostate cancer. Brachytherapy 2006, 5:157-164.
12. Murtola T.J., Tammela T.L., Maattanen L., et al. Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial. Int J Cancer 2010, 127:1650-1659.
13. Breau R.H., Karnes R.J., Jacobson D.J., et al. The association between statin use and the diagnosis of prostate cancer in a population based cohort. J Urol 2010, 184:494-499.
14. Shannon J., Tewoderos S., Garzotto M., et al. Statins and prostate cancer risk: A case-control study. Am J Epidemiol 2005, 162:318-325.
15. Bonovas S., Filioussi K., Sitaras N.M. Statin use and the risk of prostate cancer: A metaanalysis of 6 randomized clinical trials and 13 observational studies. Int J Cancer 2008, 123:899-904.
16. Agalliu I., Salinas C.A., Hansten P.D., et al. Statin use and risk of prostate cancer: Results from a population-based epidemiologic study. Am J Epidemiol 2008, 168:250-260.
17. Nielsen S.F., Nordestgaard B.G., Bojesen S.E. Statin use and reduced cancer-related mortality. N Engl J Med 2012, 367:1792-1802.
18. Moyad M.A., Merrick G.S., Butler W.M., et al. Statins, especially atorvastatin, may improve survival following brachytherapy for clinically localized prostate cancer. Urol Nurs 2006, 26:298-303.
19. Alizadeh M., Sylvestre M.P., Zilli T., et al. Effect of statins and anticoagulants on prostate cancer aggressiveness. Int J Radiat Oncol Biol Phys 2012, 83:1149-1153.
20. Mener D.J., Cambio A., Stoddard D.G., et al. The impact of HMG-CoA reductase therapy on serum PSA. Prostate 2010, 70:608-615.
21. Ritch C.R., Hruby G., Badani K.K., et al. Effect of statin use on biochemical outcome following radical prostatectomy. BJU Int 2011, 108:E211-E216.